m+Medelevator.RU
← Поиск публикаций
Cell reports · 2025

Patient-derived organoids to study glycosylation dynamics during gastric disease.

СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Santos-Ferreira Liliana, Martins Álvaro M, Duarte Henrique O, Moia Eva, Costa Ana F, de Ru Arnoud H, Faria-Ramos Isabel, Matos Rita, Barros Rita, Cavadas Bruno, Silva Marta, Pedrosa Sofia, Batista Diana A, Gomes Joana, Borén Thomas, Sousa Fabiana, Casanova-Gonçalves Frederica, Barbosa José, Magalhães Ana, Gomes Catarina, Santos-Sousa Hugo, Bartfeld Sina, Wuhrer Manfred, de Haan Noortje, Carneiro Fátima, Reis Celso A, Pinto Filipe

Аннотация

Aberrant cellular glycosylation is a key event that accompanies and actively sustains gastric neoplastic transformation. Patient-derived organoids (PDOs) have recently emerged as promising ex vivo models to study human gastric diseases; however, their glycosylation landscape remains unknown. To evaluate gastric PDOs as avatars of in vivo tissue glycosylation, a biobank of gastric PDOs (n = 56) was generated from gastric mucosa samples of non-tumoral obese patients (n = 11), adjacent tumor mucosa (n = 26), and gastric tumor tissue (n = 19). PDOs reproduce distinct stages of gastric carcinogenesis and recapitulate the gastric tissue-associated glycosylation profiles. PDOs capture glycan inter- and intra-tumoral heterogeneity, which is maintained over time and upon biobanking and xenografting. Furthermore, expression of type I/II Lewis antigens is dynamically controlled by the PDO's differentiation status, influencing Helicobacter pylori binding, mirroring the gastric epithelium-tissue interactions. This study establishes PDOs as robust ex vivo tools to study gastric glycan dynamics in both gastric physiological and pathological settings.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты